An ultra-sensitive fluorescence biosensor with rolling circle amplification and CRISPR/Cas12a one-pot system for FEN1 detection.

Autor: He XL; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China., Song YL; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China., Ma LY; Department of Pharmacy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, 430030, China., Jiang M; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China., Xu L; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: xulpharm@mails.tjmu.edu.cn., Yu X; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: xuyu@hust.edu.cn.
Jazyk: angličtina
Zdroj: Talanta [Talanta] 2024 Nov 04; Vol. 283, pp. 127159. Date of Electronic Publication: 2024 Nov 04.
DOI: 10.1016/j.talanta.2024.127159
Abstrakt: Flap endonuclease 1 (FEN1), a structure-specific nuclease, has been reported to be widely involved in the development of cancer, and recognized as a new biomarker for cancer. However, there remains a deficiency in the availability of simple, rapid and reliable biosensors for its detection. We have constructed a cascade signal amplification fluorescence biosensor for ultra-sensitive and rapid detection of FEN1. This biosensor relied on FEN1-induced production of the 5' flap DNA, and combined rolling circle amplification (RCA) and CRISPR/Cas12a one-pot system (RCOS). By utilizing branched dsDNA substrates to provoke FEN1 activity, the 5' flap DNA was cleaved and isolated through magnetic separation. Subsequently, these DNA fragments initiated the RCA and CRISPR/Cas12a one-pot exponential amplification reaction, activating the cis and trans-cleavage activity of Cas12a and resulting in a significant fluorescence signal for readout. By combining RCA and CRISPR/Cas12a one-pot cascade signal amplification, the detection signal was remarkable enhanced. The RCOS exhibited excellent sensitivity with a limit of detection (LOD) of 4.1 × 10 -7 U/μL, which was more sensitive and expeditious than many other approaches. Furthermore, the biosensor successfully facilitated accurate determination of FEN1 in cell extracts and plasma samples, revealing the potential clinical application and providing a dependable and rapid approach for FEN1 inhibitor screening. Compared with traditional methods, this approach has several benefits including improving the selectivity and sensitivity for FEN1 assay, reducing the complex operation process, and providing a method for the FEN1 inhibition screening.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: